News
02-04-2011, 10:10 PM
EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.
More... (http://www.news-medical.net/news/20110204/EntreMed-announces-publication-of-ENMD-2076-Phase-1-results-against-solid-tumors-in-AACR-journal.aspx)
More... (http://www.news-medical.net/news/20110204/EntreMed-announces-publication-of-ENMD-2076-Phase-1-results-against-solid-tumors-in-AACR-journal.aspx)